Literature DB >> 10444506

Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations.

M L Coker1, M A Doscher, C V Thomas, Z S Galis, F G Spinale.   

Abstract

In several cardiac disease states, alterations in myocyte and extracellular matrix (ECM) structure occur with left ventricular (LV) remodeling and are associated with changes in matrix metalloproteinase (MMP) activity. Although nonmyocyte cell types have been implicated as sites for synthesis and expression of MMPs within the ECM, whether the LV myocyte itself expresses specific types and active forms of MMPs remains unknown. Accordingly, isolated Ca(2+)-tolerant LV porcine myocytes (10(5) cells/ml) in which selective disaggregation and resuspension was performed (13 independent experiments) were plated on basement membrane substrates including Matrigel, collagen IV, laminin, and fibronectin as well as poly-L-lysine. After 24-h incubation, LV myocyte conditioned media were subjected to zymography, a specific MMP-2 proteolytic capture assay, immunoblotting, and ELISA for detection of MMP activity and relative content of the 72-kDa gelatinase MMP-2. Although robust zymographic activity [(pixels. mm(2))/cell] was observed in conditioned media from LV myocytes plated on collagen IV (1,673 +/- 297), fibronectin (1,530 +/- 281), and poly-L-lysine (2,545 +/- 560), proteolytic activity appeared to be lower in conditioned media from LV myocytes plated on Matrigel (842 +/- 83) and laminin (1,329 +/- 238). MMP-2 proteolytic activity was increased by approximately eightfold in conditioned media taken from LV myocytes plated on poly-L-lysine compared with that of Matrigel. With respect to each of the adhesion substrates, MMP-2 content was at least 50% lower in LV myocyte conditioned media taken from Matrigel and laminin. Immunofluorescent labeling of LV myocytes yielded a strong signal for MMP-2 within the myocyte and along the sarcolemmal surface. In conclusion, this study demonstrated for the first time that adult LV myocytes synthesize and express members of the MMP family and thus may potentially participate in the LV remodeling process through synthesis and secretion of MMPs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444506     DOI: 10.1152/ajpheart.1999.277.2.H777

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.

Authors:  Wenjie Wang; Serena Viappiani; Jolanta Sawicka; Richard Schulz
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.

Authors:  Mohammad A M Ali; Woo Jung Cho; Bryan Hudson; Zamaneh Kassiri; Henk Granzier; Richard Schulz
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

3.  Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.

Authors:  I Friehs; R E Margossian; A M Moran; H Cao-Danh; M A Moses; P J del Nido
Journal:  Basic Res Cardiol       Date:  2005-12-23       Impact factor: 17.165

Review 4.  Screening for ventricular remodeling.

Authors:  Douglas S Lee; Thomas J Wang; Ramachandran S Vasan
Journal:  Curr Heart Fail Rep       Date:  2006-04

5.  AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis.

Authors:  Nikhlesh K Singh; Dong Van Quyen; Venkatesh Kundumani-Sridharan; Peter C Brooks; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

6.  Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction.

Authors:  Sayyed Mohammad Hossein Ghaderian; Reza Akbarzadeh Najar; Akram Sadat Tabatabaei Panah; Gashin Rezaie; Azam Rezaei Farimani; Asghar Beigi Harchegani; Eznollah Azargashb
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

7.  The epitope-mediated MMP activation assay: detection and quantification of the activation of Mmp2 in vivo in the zebrafish embryo.

Authors:  Emma J Jeffrey; Bryan D Crawford
Journal:  Histochem Cell Biol       Date:  2018-01-19       Impact factor: 4.304

8.  Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation.

Authors:  D J Schupp; B P Huck; J Sykora; C Flechtenmacher; M Gorenflo; A Koch; F-U Sack; M Haass; H A Katus; H E Ulmer; S Hagl; H F Otto; P A Schnabel
Journal:  Virchows Arch       Date:  2005-09-14       Impact factor: 4.064

Review 9.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo.

Authors:  Nozomu Matsunaga; Yuichi Chikaraishi; Masamitsu Shimazawa; Shigeru Yokota; Hideaki Hara
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.